HERON THERAPEUTICS INC (HRTX) Stock Institutional Trading Activity


HERON THERAPEUTICS INC (HRTX) position changes reported by tracked institutional filers across multiple SEC 13F reporting periods. Based on recent SEC 13F filings (Q4 2025), investors with some of the largest reported share count changes include Renaissance Technologies LLC. Explore insights into buying and selling patterns, position changes, and investment conviction levels to understand institutional trading behavior and market dynamics.

Explore more:

Portfolio quarterNameTypeQuantityRemainingReported stock balance
Q4 2025Renaissance Technologies LLCSell-939,0991,915,900$2,490,670
Q3 2025Renaissance Technologies LLCBuy165,6602,854,999$3,597,299
Q2 2025Renaissance Technologies LLCBuy414,8392,689,339$5,566,932
Q1 2025Renaissance Technologies LLCBuy1,085,7002,274,500$5,003,900
Q4 2024Renaissance Technologies LLCSell-819,3981,188,800$1,818,864
Q3 2024Renaissance Technologies LLCBuy14,3982,008,198$3,996,314
Q2 2024Renaissance Technologies LLCSell-412,6861,993,800$6,978,300
Q1 2024Renaissance Technologies LLCBuy523,1862,406,486$6,666
Q4 2023Renaissance Technologies LLCBuy1,592,0001,883,300$3,202
Q3 2023Renaissance Technologies LLCSell-767,800291,300$300
Q2 2023Renaissance Technologies LLCSell-81,7361,059,100$1,229
Q1 2023Renaissance Technologies LLCBuy814,3361,140,836$1,723
Q4 2022Renaissance Technologies LLCBuy163,900326,500$816
Q1 2021Renaissance Technologies LLCBuy27,800162,600$2,636
Q3 2020Renaissance Technologies LLCSell-105,000134,800$1,998
Q2 2020Renaissance Technologies LLCSell-812,092239,800$3,527
Q1 2020Renaissance Technologies LLCBuy870,8921,051,892$12,349
Q4 2019Renaissance Technologies LLCBuy83,600181,000$4,254
Q2 2019Renaissance Technologies LLCSell-36,70097,400$1,811
Q3 2018Renaissance Technologies LLCBuy54,300134,100$4,244
Q4 2017Renaissance Technologies LLCBuy31,70079,800$1,444
Q2 2015Renaissance Technologies LLCBuy48,10048,100$1,499

Frequently asked questions about HRTX activity

  • Which institutional owners are buying HRTX?

    Institutional owners buying HRTX include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.

  • What does "buy" mean in HRTX activity?

    "Buy" means an investor increased their reported position in HRTX compared to the prior reporting period. This reflects growing exposure to HERON THERAPEUTICS INC (HRTX) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).

  • Is institutional interest in HRTX increasing?

    Institutional interest in HRTX can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.